ATRY — Atrys Health SA Income Statement
0.000.00%
- €216.37m
- €424.06m
- €212.74m
- 23
- 54
- 47
- 32
Annual income statement for Atrys Health SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.4 | 121 | 158 | 202 | 213 |
Cost of Revenue | |||||
Gross Profit | 24.3 | 101 | 126 | 142 | 145 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 29.5 | 136 | 172 | 202 | 223 |
Operating Profit | 1.92 | -15.4 | -13.4 | -0.887 | -10.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.31 | -24.9 | -26.8 | -33.7 | -33.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.02 | -23.2 | -26 | -30.8 | -31.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.02 | -23.3 | -23.1 | -45.6 | -31.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.02 | -23.3 | -23.1 | -45.6 | -31.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.071 | -0.456 | -0.349 | -0.404 | -0.26 |